Ghiath M. Sukhtian
CIK: 0001717441
Transaction Breakdown
Open Market Buys (P)2 (16.7%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)2 (16.7%)
Derivative conversions
Awards (A)4 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)4 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
OTLK
Outlook Therapeutics, Inc.
Director10% Owner
Discretionary Trading P&L
Holdings
Transaction History
About Sukhtian Ghiath M.
Sukhtian Ghiath M. (SEC CIK 0001717441) files insider reports with the SEC as Director of Outlook Therapeutics, Inc. (OTLK).
Signal8 holds 5 ownership filings by Sukhtian Ghiath M., all Form 4s, filed between Jan 22, 2025 and Aug 14, 2026. Those filings report 12 transactions, from Jan 17, 2025 to Aug 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Sukhtian Ghiath M.'s filings is in AMMAN.
Other insiders filing for Outlook Therapeutics, Inc. (OTLK)
- Lundquist Kevin Michael, Chief Financial Officer
- Jahr Robert Charles, Chief Executive Officer
- KENYON LAWRENCE A, Chief Financial Officer
- Sukhtian Faisal Ghiath, Director
- Haddadin Yezan Munther, Director
- THURMAN RANDY H, Director